TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/11/23 16:05 | 4/8/23 | KROS | Keros Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Seehra Jasbir | MA | DO | CEO | M.d | 2 | 0.4800 | 0 | 4 | 2 | 253 | D | |||||||||||||||
6/10/22 16:12 | 6/9/22 | KROS | Keros Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Seehra Jasbir | MA | DO | CEO | M.d | 2 | 0.3000 | 0 | 5 | 2 | 249 | D | ||||||||||||||
4/13/20 17:19 | 4/13/20 | KROS | Keros Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Seehra Jasbir | MA | DO | CEO | P.d | 320 | 16.00 | 0 | 20 | 9 | 244 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |